infect
novel
coronaviru
found
wuhan
china
rapidli
spread
incid
rate
increas
worldwid
due
lack
effect
treatment
option
variou
strategi
test
china
includ
drug
repurpos
studi
use
pretrain
deep
learningbas
drugtarget
interact
model
call
molecul
transformerdrug
target
interact
mtdti
identifi
commerci
avail
drug
could
act
viral
protein
result
show
atazanavir
antiretrovir
medic
use
treat
prevent
human
immunodefici
viru
hiv
best
chemic
compound
show
inhibitori
potenc
kd
nm
proteinas
follow
efavirenz
nm
ritonavir
nm
dolutegravir
nm
interestingli
lopinavir
ritonavir
darunavir
design
target
viral
proteinas
howev
predict
may
also
bind
replic
complex
compon
inhibitori
potenc
kd
nm
addit
also
found
sever
antivir
agent
kaletra
could
use
treatment
although
realworld
evid
support
predict
overal
suggest
list
antivir
drug
identifi
mtdti
model
consid
establish
effect
treatment
strategi
coronavirus
cov
belong
famili
coronavirida
positivesens
envelop
rna
virus
caus
infect
bird
mammal
human
famili
includ
four
genera
alphacoronaviru
betacoronaviru
deltacoronaviru
gammacoronaviru
two
infam
infecti
coronavirus
genu
betacoronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
peopl
around
world
past
two
decad
unfortun
incid
accompani
high
mortal
rate
sarscov
merscov
indic
urgent
need
effect
treatment
begin
outbreak
prevent
spread
howev
achiev
current
drug
develop
applic
system
take
sever
year
newli
develop
drug
come
market
unexpectedli
world
face
situat
previou
outbreak
due
recent
epidem
atyp
pneumonia
caus
novel
coronaviru
wuhan
china
thu
rapid
drug
applic
strategi
immedi
appli
patient
necessari
current
way
address
matter
repurpos
commerci
avail
drug
pathogen
socal
drugrepurpos
howev
theori
artifici
intellig
ai
base
architectur
must
taken
account
order
accur
predict
drugtarget
interact
dti
enorm
amount
complex
inform
eg
hydrophob
interact
ionic
interact
hydrogen
bond
andor
van
der
waal
forc
molecul
end
previous
develop
deep
learningbas
drugtarget
interact
predict
model
call
molecul
transformerdrug
target
interact
mtdti
studi
appli
pretrain
mtdti
model
identifi
commerci
avail
antivir
drug
could
potenti
disrupt
viral
compon
proteinas
rnadepend
rna
polymeras
andor
helicas
sinc
model
util
simplifi
molecularinput
lineentri
system
smile
string
amino
acid
aa
sequenc
string
input
possibl
quickli
appli
target
protein
experiment
confirm
crystal
structur
viral
protein
share
list
top
commerci
avail
antivir
drug
could
potenti
hinder
multipl
cycl
hope
effect
drug
develop
base
aipropos
drug
candid
act
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doiorg
amino
acid
sequenc
proteinas
access
rnadepend
rna
polymeras
access
helicas
access
exonucleas
access
endornas
access
methyltransferas
access
replic
complex
extract
whole
genom
sequenc
access
nation
center
biotechnolog
inform
ncbi
databas
raw
predict
result
screen
antivir
drug
fda
approv
target
viral
protein
kd
valu
less
nm
molecul
transformerdrug
target
interact
mtdti
use
predict
bind
affin
valu
commerci
avail
antivir
drug
target
protein
briefli
natur
languag
process
nlp
base
bidirect
encod
represent
transform
bert
framework
core
algorithm
model
good
perform
robust
result
divers
drugtarget
interact
dataset
pretrain
chemic
languag
smile
approxim
compound
train
model
drug
target
common
dtc
databas
bindingdb
databas
manual
curat
combin
three
type
efficaci
valu
ki
kd
integr
consistencescorebas
averag
algorithm
make
pearson
correl
score
term
ki
kd
sinc
bindingdb
databas
includ
wide
varieti
speci
target
protein
mtdti
model
potenti
power
predict
interact
antivir
drug
protein
proteinas
predict
bind
atazanavir
kd
nm
follow
efavirenz
ritonavir
antivir
drug
predict
affin
kd
nm
potenc
tabl
proteas
inhibitor
antivir
drug
found
kd
nm
rang
although
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doiorg
realworld
evid
whether
drug
act
predict
yet
case
studi
identifi
exampl
dock
studi
lopinavir
along
hiv
proteinas
inhibitor
cov
proteinas
pdbid
suggest
atazanavir
ritonavir
list
present
predict
result
may
inhibit
cov
proteinas
line
inhibitori
potenc
lopinavir
accord
predict
viral
proteinasetarget
drug
predict
act
favor
viral
replic
process
viral
proteinas
dti
model
tabl
result
includ
antivir
drug
proteinas
inhibitor
guanosin
analogu
eg
acyclovir
ganciclovir
penciclovir
revers
transcriptas
inhibitor
integras
inhibitor
among
predict
result
atazanavir
predict
potenti
bind
affin
bind
tabl
also
ganciclovir
predict
bind
three
subunit
replic
complex
rnadepend
rna
polymeras
kd
nm
exonucleas
kd
nm
rna
helicas
kd
nm
lopinavir
ritonavir
activ
materi
abbvi
kaletra
predict
potenti
affin
helicas
tabl
suggest
potenti
mer
therapeut
recent
approxim
million
worth
kaletra
dose
donat
china
previou
clinic
studi
sar
chu
et
al
may
support
decis
anoth
antihiv
drug
prezcobix
johnson
johnson
consist
darunavir
cobicistat
sent
china
darunavir
also
predict
kd
nm
helicas
tabl
howev
current
support
literatur
found
darunavir
use
cov
therapeut
mani
case
dti
predict
model
serv
tool
repurpos
drug
develop
novel
usag
exist
drug
howev
applic
dti
predict
present
studi
may
use
control
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
tabl
drugtarget
interact
dti
predict
result
fda
approv
antvir
drug
avail
market
novel
coronaviru
ncbi
refer
sequenc
proteinas
access
ritonavir
express
canon
isomer
form
smile
indic
isomer
form
smile
ritonavir
tabl
drugtarget
interact
dti
predict
result
antivir
drug
avail
market
novel
coronaviru
ncbi
refer
sequenc
helicas
access
ritonavir
express
canon
isomer
form
smile
indic
isomer
form
smile
ritonavir
copyright
holder
preprint
peerreview
http
doiorg
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
tabl
drugtarget
interact
dti
predict
result
antivir
drug
avail
market
novel
coronaviru
ncbi
refer
sequenc
methyltransferas
access
copyright
holder
preprint
peerreview
http
doiorg
